CJC-1295 (no DAC)
Mod GRF 1-29 · Modified GRF · CJC-1295 without DAC
A GHRH analog with a very short half-life, typically paired with a GHRP such as Ipamorelin.
At a glance
- Category
- Growth Hormone
- Half-life
- Not characterised
- Typical vial sizes
- 2 mg · 5 mg
Concentration by water volume
Pure arithmetic: the vial strength divided by the water added. The dose itself comes from your clinician, pharmacy, product instructions, or research protocol — enter it in the calculator below.
| Vial | Water added | Concentration | Per U-100 unit |
|---|---|---|---|
| 2 mg | 1 mL | 2 mg/mL | 20 mcg |
| 2 mg | 2 mL | 1 mg/mL | 10 mcg |
| 2 mg | 3 mL | 0.667 mg/mL | 6.667 mcg |
| 5 mg | 1 mL | 5 mg/mL | 50 mcg |
| 5 mg | 2 mL | 2.5 mg/mL | 25 mcg |
| 5 mg | 3 mL | 1.667 mg/mL | 16.667 mcg |
Storage
- Lyophilised (unmixed)
- Refrigerated, protected from light.
- Reconstituted
- Refrigerate at 2–8°C.
What people log it against
Outcomes users commonly track alongside this compound. Listing them is not a claim that it produces them.
- Growth hormone pulse support
- Recovery
Read alongside CJC-1295 (no DAC)
Compounds this one is commonly compared with or mistaken for. Listing a pairing is not a suggestion to use them together.
- CJC-1295 with DACResearch use onlyOne name, two different compounds. The DAC version has a half-life measured in days; without DAC it is short-acting. Anything that omits the suffix is ambiguous about which compound it means.
- IpamorelinResearch use onlyOften discussed together: ipamorelin is a GHRP and CJC-1295 without DAC a GHRH analogue, acting on different receptors in the same growth-hormone pathway.
- SermorelinNot FDA-approvedBoth GHRH analogues. CJC-1295 without DAC is a modified GRF(1-29); sermorelin is the unmodified sequence, and is the one with an approved-drug history.
References
Each source below establishes only the specific claim noted with it, last checked 2026-08-13. Storage times reflect common handling guidance and are not established by these references.
- Coy et al., JCEM 1994 (D-Ala2 GHRH(1-29)) — PMID 7962295
IV infusion in 10 normal men: disappearance half-time 4.3 +/- 1.4 min for GHRH(1-29)-NH2 and 6.7 +/- 0.5 min for the D-Ala2 analogue, with MCR falling from 39.7 to 21 mL/kg/min. D-Ala2 is one of the substitutions in modified GRF(1-29), so the backbone clears in SINGLE-DIGIT MINUTES. No primary PK study of the full tetrasubstituted peptide exists, and the widely repeated 30 min figure has no published source and is not consistent with this data. Null rather than a fabricated number.
Run your own numbers
Enter the dose and concentration from your clinician, pharmacy, product instructions, or research protocol. VialPal handles the math.
As printed on the vial label
How much water you add to the vial
From your clinician, pharmacy, product instructions, or research protocol. 1000 mcg = 1 mg
Fills in a vial size this compound is commonly sold in. It does not fill in a dose — check the size against your own vial label.
Enter your numbers
Still needed: vial strength, bacteriostatic water, dose. Use the figures on your vial label and the dose from your clinician, pharmacy, product instructions, or research protocol — VialPal handles the math.
Keep this vial. VialPal holds the concentration, counts down the doses left in it, and logs the ones you actually took.
Get VialPalVialPal does the arithmetic — it does not tell you what to take. Dose decisions belong between you and a qualified clinician.